AVELUMAB

UNII: KXG2PJ551I
Preferred Substance Name: AVELUMAB

1537032-82-8
AVELUMAB [INN]
AVELUMAB [JAN]
AVELUMAB [MI]
AVELUMAB [PURPLE BOOK CDER]
AVELUMAB [USAN]
AVELUMAB [WHO-DD]
BAVENCIO
IMMUNOGLOBULIN G1-LAMBDA1, ANTI-(HOMO SAPIENS CD274 (PROGRAMMED DEATH LIGAND 1, PDL1, PD-L1, B7 HOMOLOG 1, B7H1)), HOMO SAPIENS MONOCLONAL ANTIBODY
MSB0010682
MSB-0010682
MSB0010718C
MSB-0010718C

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

About, Contact Us, Copyright, Privacy, Accessibility

U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993-0002

U.S. Food and Drug Administration, Health & Human Services

Freedom of Information Act

AVELUMAB

Synonyms and Mappings

Resources

Note